autores
- xmlui.general.dspace_homeCentros e Institutos de InvestigaciónCICVyA. Centro de Investigación en Ciencias Veterinarias y AgronómicasInstituto de BiotecnologíaArtículos científicosxmlui.ArtifactBrowser.ConfigurableBrowse.trail.metadata.authorArtículos científicos
- Inicio
- Centros e Institutos de Investigación
- CICVyA. Centro de Investigación en Ciencias Veterinarias y Agronómicas
- Instituto de Biotecnología
- Artículos científicos
- autores
Autores
Mostrando ítems 1-2 de 2
-
Assessing the hidden diversity underlying consensus sequences of SARS-CoV-2 using VICOS, a novel bioinformatic pipeline for identification of mixed viral populations
Goya, Stephanie; Sosa, Ezequiel Jorge; Nabaes Jodar, Mercedes Soledad; Torres, Carolina; Konig, Guido Alberto; Acuña, Dolores; Ceballos, Santiago; Distefano, Ana Julia; Dopazo, Hernán; Dus Santos, Maria Jose; Fass, Monica Irinia; Fernandez Do Porto, Darío Augusto; Fernandez, Ailen; Gallego, Fernando; Gismondi, Maria Ines; Gramundi, Ivan; Lusso, Silvina; Marti, Marcelo Adrián; Mazzeo, Melina; Mistchenko, Alicia Susana; Muñoz Hidalgo, Marianne Graziel; Natale, Mónica; Nardi, Cristina; Ousset, Julia; Peralta, Andrea Veronica; Pintos, Carolina; Puebla, Andrea Fabiana; Pianciola, Luis; Rivarola, Maximo Lisandro; Turjanski, Adrián; Valinotto, Laura; Vera, Pablo Alfredo; Zaiat, Jonathan; Zubrycki, Jeremias Enrique; Aulicino, Paula; Viegas, Mariana (Elsevier, 2023-02)Introduction: Coinfection with two SARS-CoV-2 viruses is still a very understudied phenomenon. Although next generation sequencing methods are very sensitive to detect heterogeneous viral populations in a sample, there is ... -
Single nucleotide polymorphisms may explain the contrasting phenotypes of two variants of a multidrug-resistant Mycobacterium tuberculosis strain
Bigi, María Mercedes; López, Beatriz; Blanco, Federico Carlos; Sasiain, María del Carmen; De La Barrera, Silvia Susana; Marti, Marcelo Adrián; Sosa, Ezequiel Jorge; Fernandez Do Porto, Darío Augusto; Ritacco, Viviana; Bigi, Fabiana; Soria, Marcelo Abel (2017)Globally, about 4.5% of new tuberculosis (TB) cases are multi-drug-resistant (MDR), i.e. resistant to the two most powerful first-line anti-TB drugs. Indeed, 480,000 people developed MDR-TB in 2015 and 190,000 people died ...